Development of Foot and Mouth Disease Vaccine Formulation in Egypt by Using Silver Nanoparticles as Immunogenic and Adjuvant Corresponding author: Name: Rania Dweek, Tel: 01009377501 E-mail : [email protected]

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Rania Dweek
Author(s):  
Willy Kelvin CANDEIRA ◽  
Luciano Santos da FONSECA ◽  
Roberto Carlos Negreiros de ARRUDA ◽  
Layza Michelle de Azevedo FREITAS ◽  
Hilmanara Tavares da SILVA ◽  
...  

ABSTRACT The aim of the present study is to identify the occurrence of abscesses in cattle after the administration of bivalent foot-and-mouth disease vaccine as adverse reaction to components in the new commercial vaccine formulation. Thirty bovines were divided into three groups composed of 10 animals, each. Groups 1 and 2 were vaccinated by researchers based on good vaccination practices criteria. Group 1 was intramuscularly administered with the vaccine, Group 2 received it through subcutaneous route and Group 3 was vaccinated by breeders through subcutaneous route. Animals were selected and observed in vivo in three different moments (7, 28 and 45 days after vaccination). Subsequently, they were observed during post mortem inspection in order to assess the occurrence of vaccine abscesses. Vaccine abscesses were recorded in 40% of bovines in Group 1, in 50% of the ones in Group 2 and in 60% of those in Group 3. There was no significant difference between experimental groups based on the Chi-square test and on Cramer's V analysis; there was no significant difference among experimental groups. Excess of carcass parts presenting vaccine abscesses during post mortem inspection resulted in the meat loss of 1.775 kg in Group 1, of 2.303 kg in Group 2 and of 3.268 kg in Group 3. In conclusion, despite changes in bivalent foot-and-mouth disease vaccine formulation, care should be taken at vaccination time to minimize the occurrence of vaccine abscesses and, consequently, meat losses at slaughter, as well as to reduce losses in beef production chain.


2019 ◽  
Vol 9 (2) ◽  
pp. 244-251
Author(s):  
T. Anitha Sironmani

Background: Foot and mouth disease (FMD) is caused by a virus of the genus Aphthovirus, family Picornaviridae which includes several members of medical importance, Multiple subtypes or antigenic variants within each serotype, which make the vaccine from one serotype does not confer protection against the other serotype. Methods: Green synthesized silver nanoparticles were functionalized with FMDV antigen /antibody. The functionalized silver nanoparticles were characterized by UV -Visible spectrophotometer, Fluorescence Spectrophotometer etc. Immunomodulation study, efficacy and toxicity tests on the final product were carried out. Results: The protein profile after immunoprecipitation with AntiFMD antibody analysed on a 12.5% SDS-PAGE which corresponded to the viral proteins. The western blot analysis confirmed the same pattern. When the infected mice were treated with functionalised silver nanoparticles, all mice were recovered from the disease within 12 hrs. The field trial of these nanoformulations showed 100% recovery of the animals with minimum neutralizing antibody without any other physiological problems. Conclusion: Surface modification of silver nanoparticles can create multifunctional materials with potential applications. Nanoformulations developed by functionalizing whole FMD viral protein /antibody with that of silver nanoparticles, elicite an optimal immuno-protective response and as diagnostic agent against foot and mouth disease causing virus The easy method of preparation of nanoparticle, the flexibility of functionalization techniques, long shelf life without cold chain protection and minimum single low dosage reveals the feasibility of this nanoformulation applications ranging from prophylactic vaccines, diagnostics, therapy for all infections leading to autoimmune diseases.


2018 ◽  
Vol 8 (2) ◽  
pp. 248-254 ◽  
Author(s):  
Solmaz Rafiei ◽  
Seyedeh E. Rezatofighi ◽  
Mohammad R. Ardakani ◽  
Omid Madadgar

Vaccines ◽  
2019 ◽  
Vol 7 (3) ◽  
pp. 90 ◽  
Author(s):  
Raj Kumar Singh ◽  
Gaurav Kumar Sharma ◽  
Sonalika Mahajan ◽  
Kuldeep Dhama ◽  
Suresh H. Basagoudanavar ◽  
...  

A mass vaccination campaign in India seeks to control and eventually eradicate foot-and-mouth disease (FMD). Biosanitary measures along with FMD monitoring are being conducted along with vaccination. The implementation of the FMD control program has drastically reduced the incidence of FMD. However, cases are still reported, even in regions where vaccination is carried out regularly. Control of FMD outbreaks is difficult when the virus remains in circulation in the vaccinated population. Various FMD risk factors have been identified that are responsible for FMD in vaccinated areas. The factors are discussed along with strategies to address these challenges. The current chemically inactivated trivalent vaccine formulation containing strains of serotype O, A, and Asia 1 has limitations including thermolability and induction of only short-term immunity. Advantages and disadvantages of several new-generation alternate vaccine formulations are discussed. It is unfeasible to study every incidence of FMD in vaccinated animals/areas in such a big country as India with its huge livestock population. However, at the same time, it is absolutely necessary to identify the precise reason for vaccination failure. Failure to vaccinate is one reason for the occurrence of FMD in vaccinated areas. FMD epidemiology, emerging and re-emerging virus strains, and serological status over the past 10 years are discussed to understand the impact of vaccination and incidences of vaccination failure in India. Other factors that are important in vaccination failure that we discuss include disrupted herd immunity, health status of animals, FMD carrier status, and FMD prevalence in other species. Recommendations to boost the search of alternate vaccine formulation, strengthen the veterinary infrastructure, bolster the real-time monitoring of FMD, as well as a detailed investigation and documentation of every case of vaccination failure are provided with the goal of refining the control program.


2016 ◽  
Vol 97 (7) ◽  
pp. 1557-1565 ◽  
Author(s):  
Abhay Kotecha ◽  
Fuquan Zhang ◽  
Nicholas Juleff ◽  
Terry Jackson ◽  
Eva Perez ◽  
...  

RSC Advances ◽  
2017 ◽  
Vol 7 (3) ◽  
pp. 1453-1463 ◽  
Author(s):  
Yinghua Li ◽  
Zhengfang Lin ◽  
Tiantian Xu ◽  
Changbing Wang ◽  
Mingqi Zhao ◽  
...  

Enterovirus 71 (EV71) is the primary causative agent of hand, foot, and mouth disease (HFMD).


Author(s):  
Sydney S. Breese ◽  
Howard L. Bachrach

Continuing studies on the physical and chemical properties of foot-and-mouth disease virus (FMDV) have included electron microscopy of RNA strands released when highly purified virus (1) was dialyzed against demlneralized distilled water. The RNA strands were dried on formvar-carbon coated electron microscope screens pretreated with 0.1% bovine plasma albumin in distilled water. At this low salt concentration the RNA strands were extended and were stained with 1% phosphotungstic acid. Random dispersions of strands were recorded on electron micrographs, enlarged to 30,000 or 40,000 X and the lengths measured with a map-measuring wheel. Figure 1 is a typical micrograph and Fig. 2 shows the distributions of strand lengths for the three major types of FMDV (A119 of 6/9/72; C3-Rezende of 1/5/73; and O1-Brugge of 8/24/73.


Author(s):  
S. S. Breese ◽  
H. L. Bachrach

Models for the structure of foot-and-mouth disease virus (FMDV) have been proposed from chemical and physical measurements (Brown, et al., 1970; Talbot and Brown, 1972; Strohmaier and Adam, 1976) and from rotational image-enhancement electron microscopy (Breese, et al., 1965). In this report we examine the surface structure of FMDV particles by high resolution electron microscopy and compare it with that of particles in which the outermost capsid protein VP3 (ca. 30, 000 daltons) has been split into smaller segments, two of which VP3a and VP3b have molecular weights of about 15, 000 daltons (Bachrach, et al., 1975).Highly purified and concentrated type A12, strain 119 FMDV (5 mg/ml) was prepared as previously described (Bachrach, et al., 1964) and stored at 4°C in 0. 2 M KC1-0. 5 M potassium phosphate buffer at pH 7. 5. For electron microscopy, 1. 0 ml samples of purified virus and trypsin-treated virus were dialyzed at 4°C against 0. 2 M NH4OAC at pH 7. 3, deposited onto carbonized formvar-coated copper screens and stained with phosphotungstic acid, pH 7. 3.


Sign in / Sign up

Export Citation Format

Share Document